Robot-assisted stereotactic biopsies in 377 consecutive adult patients with supratentorial diffuse gliomas: diagnostic yield, safety and postoperative outcomes

Author(s):  
Marc ZANELLO ◽  
Alexandre ROUX ◽  
Suhan SENOVA ◽  
Sophie PEETERS ◽  
Myriam EDJLALI ◽  
...  
2021 ◽  
Author(s):  
Iulia Peciu-Florianu ◽  
Victor Legrand ◽  
Apolline Monfilliette-Djelad ◽  
Claude-Alain Maurage ◽  
Quentin Vannod-Michel ◽  
...  

Abstract PurposeTargeted treatment for brainstem lesions requires above all a precise histopathological and molecular diagnosis. In the current technological era, robot-assisted stereotactic biopsies represent an accurate and safe procedure for tissue diagnosis. We present our center’s experience in frameless robot-assisted biopsies for brainstem lesions. MethodsWe performed a retrospective analysis of all patients benefitting from a frameless robot-guided stereotactic biopsy at our University Hospital, from 2001 to 2017. Patients consented to the use of data and/or images. The NeuroMate® robot (Renishaw™, UK) was used. We report on lesion location, trajectory strategy, histopathological diagnosis and procedure safety. ResultsOur series encompasses 96 patients (103 biopsies) treated during a 17 years period. Mean age at biopsy: 34.0 years (range 1-78). Most common location: pons (62.1%). Transcerebellar approach: 61 procedures (59.2%). Most common diagnoses: diffuse glioma (67.0%), metastases (7.8%) and lymphoma (6.8%). Non conclusive diagnosis: 10 cases (9.7%). After second biopsy this decreased to 4 cases (4.1%). Overall biopsy diagnostic yield: 95.8%. Permanent disability was recorded in 3 patients (2.9%, all adults), while transient complications in 17 patients (17.7%). Four cases of intra-tumoral hematoma were recorded (one case with rapid decline and fatal issue). Adjuvant targeted treatment was performed in 72.9% of patients. Mean follow-up (in the Neurosurgery Department): 2.2 years. ConclusionFrameless robot-assisted stereotactic biopsies can provide the initial platform towards a safe and accurate management for brainstem lesions, offering a high diagnostic yield with low permanent morbidity.


2021 ◽  
pp. 153483
Author(s):  
Sakun Santisukwongchote ◽  
Chinnachote Teerapakpinyo ◽  
Piyamai Chankate ◽  
Piti Techavichit ◽  
Atthaporn Boongird ◽  
...  

2016 ◽  
Vol 11 (2) ◽  
pp. 151-157 ◽  
Author(s):  
Kentaro Mizuno ◽  
Yoshiyuki Kojima ◽  
Satoshi Kurokawa ◽  
Hideyuki Kamisawa ◽  
Hidenori Nishio ◽  
...  

2015 ◽  
Vol 122 (2) ◽  
pp. 342-352 ◽  
Author(s):  
Michel Lefranc ◽  
Cyrille Capel ◽  
Anne-Sophie Pruvot-Occean ◽  
Anthony Fichten ◽  
Christine Desenclos ◽  
...  

OBJECT Stereotactic biopsy procedures are an everyday part of neurosurgery. The procedure provides an accurate histological diagnosis with the least possible morbidity. Robotic stereotactic biopsy needs to be an accurate, safe, frameless, and rapid technique. This article reports the clinical results of a series of 100 frameless robotic biopsies using a Medtech ROSA device. METHODS The authors retrospectively analyzed their first 100 frameless stereotactic biopsies performed with the robotic ROSA device: 84 biopsies were performed by frameless robotic surface registration, 7 were performed by robotic bone fiducial marker registration, and 9 were performed by scalp fiducial marker registration. Intraoperative flat-panel CT scanning was performed concomitantly in 25 cases. The operative details of the robotic biopsies, the diagnostic yield, and mortality and morbidity data observed in this series are reported. RESULTS A histological diagnosis was established in 97 patients. No deaths or permanent morbidity related to surgery were observed. Six patients experienced transient neurological worsening. Six cases of bleeding within the lesion or along the biopsy trajectory were observed on postoperative CT scans but were associated with transient clinical symptoms in only 2 cases. Stereotactic surgery was performed with patients in the supine position in 93 cases and in the prone position in 7 cases. The use of fiducial markers was reserved for posterior fossa biopsy via a transcerebellar approach, via an occipital approach, or for pediatric biopsy. CONCLUSIONS ROSA frameless stereotactic biopsies appear to be accurate and safe robotized frameless procedures.


2020 ◽  
Vol 75 (11) ◽  
pp. 645
Author(s):  
Jessie Hu ◽  
Crystal Bonnichsen ◽  
Joseph Dearani ◽  
Devon Aganga ◽  
Jonathan Johnson ◽  
...  

2019 ◽  
Vol 45 (10) ◽  
pp. 1487-1489
Author(s):  
Damien Contou ◽  
◽  
Romain Sonneville ◽  
Armand Mekontso Dessap ◽  
Nicolas de Prost

2020 ◽  
Vol 19 (3) ◽  
pp. 292-301
Author(s):  
Georgi Minchev ◽  
Gernot Kronreif ◽  
Wolfgang Ptacek ◽  
Joachim Kettenbach ◽  
Alexander Micko ◽  
...  

Abstract BACKGROUND Most brain biopsies are still performed with the aid of a navigation-guided mechanical arm. Due to the manual trajectory alignment without rigid skull contact, frameless aiming devices are prone to considerably lower accuracy. OBJECTIVE To compare a novel minimally invasive robot-guided biopsy technique with rigid skull fixation to a standard frameless manual arm biopsy procedure. METHODS Accuracy, procedural duration, diagnostic yield, complication rate, and cosmetic result were retrospectively assessed in 40 consecutive cases of frameless stereotactic biopsies and compared between a minimally invasive robotic technique using the iSYS1 guidance device (iSYS Medizintechnik GmbH) (robot-guided group [ROB], n = 20) and a manual arm-based technique (group MAN, n = 20). RESULTS Application of the robotic technique resulted in significantly higher accuracy at entry point (group ROB median 1.5 mm [0.4-3.2 mm] vs manual arm-based group (MAN) 2.2 mm [0.2-5.2 mm], P = .019) and at target point (group ROB 1.5 mm [0.4-2.8 mm] vs group MAN 2.8 mm [1.4-4.9 mm], P = .001), without increasing incision to suture time (group ROB 30.0 min [20-45 min vs group MAN 32.5 min [range 20-60 min], P = .09) and significantly shorter skin incision length (group ROB 16.3 mm [12.7-23.4 mm] vs group MAN 24.2 mm [18.0-37.0 mm], P = .008). CONCLUSION According to our data, the proposed technique of minimally invasive robot-guided brain biopsies can improve accuracy without increasing operating time while being equally safe and effective compared to a standard frameless arm-based manual biopsy technique.


2019 ◽  
Vol 13 (5) ◽  
pp. 675-687 ◽  
Author(s):  
A. J. W. Beulens ◽  
W. M. Brinkman ◽  
H. G. Van der Poel ◽  
A. N. Vis ◽  
J. P. van Basten ◽  
...  

2011 ◽  
Vol 185 (4S) ◽  
Author(s):  
Andrew P. Stegemann ◽  
Bilal Mahmood ◽  
Kevin P. Krul ◽  
Matthew H. Hayn ◽  
Mohamed A. Sharif ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document